These results demonstrate that BV is associated with CX Th17 activation and that the increased tissue-resident or CD101-expressing CX Th17 cells may contribute to a mechanism for increased HIV susceptibility in individuals with BV. The gene discussed is CD101; the disease is bacterial vaginosis.